CompletedNot Applicable

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

United States100 participantsStarted 2023-05-19

Plain-language summary

Pilot randomized controlled trial testing the investigator's previously developed storytelling method to create an interactive, multi-media storytelling intervention to address community-identified reasons for vaccine hesitancy among Black and Hispanic individuals in Central Massachusetts

Who can participate

Age range18 Years – 105 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>= 18 years of age * identifies as Black and/or Hispanic * lives in Massachusetts * vaccinated for COVID-19. Exclusion Criteria: * Unable to provide consent in English or Spanish * Has not completed the primary series of COVID-19 vaccinations (2 shots for Moderna or Pfizer, one shot for Johnson \& Johnson).

What they're measuring

Change in Vaccine Hesitancy

Timeframe: From beginning of survey to end of survey typically, 30 minutes

Trial details

NCT IDNCT06297876

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-09

View on ClinicalTrials.gov More Vaccine Hesitancy trials